Cargando…
Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
INTRODUCTION: Glycolysis affects glucose determination in vitro. The placement of sample tubes in ice-water slurry with plasma separation within 30 minutes is recommended, or alternatively the use of a glycolysis inhibitor. The aim of our two-steps study was to evaluate which Terumo tube is best for...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783092/ https://www.ncbi.nlm.nih.gov/pubmed/26981020 http://dx.doi.org/10.11613/BM.2016.006 |
_version_ | 1782420070725582848 |
---|---|
author | Bonetti, Graziella Carta, Mariarosa Montagnana, Martina Lo Cascio, Claudia Bonfigli, Anna Rita Mosca, Andrea Testa, Roberto |
author_facet | Bonetti, Graziella Carta, Mariarosa Montagnana, Martina Lo Cascio, Claudia Bonfigli, Anna Rita Mosca, Andrea Testa, Roberto |
author_sort | Bonetti, Graziella |
collection | PubMed |
description | INTRODUCTION: Glycolysis affects glucose determination in vitro. The placement of sample tubes in ice-water slurry with plasma separation within 30 minutes is recommended, or alternatively the use of a glycolysis inhibitor. The aim of our two-steps study was to evaluate which Terumo tube is best for glucose determination in routine clinical setting. MATERIALS AND METHODS: In the first study, blood from 100 volunteers was collected into lithium heparin (LH), NaF/Na heparin (FH) and NaF/citrate buffer/Na(2)EDTA (FC-Mixture) tubes. LH sample was treated as recommended and considered as reference, while FH and FC-Mixture samples were aliquoted, maintained at room temperature (RT) for 1, 2 and 4 hours; centrifuged and plasma analysed in triplicate. In the second study, samples from 375 volunteers were collected in LH, FH and FC-Mixture tubes and held at RT before centrifugation from 10 to 340 minutes, depending on each laboratory practice. Samples were analysed in one analytical run. RESULTS: In the first study, FH glucose concentrations were 5.15 ± 0.66 mmol/L, 5.05 ± 0.65 mmol/L and 5.00 ± 0.65 mmol/L (P < 0.001) in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases in all time points exceeded the analytical goal for desirable bias based on biological variation criteria. FC-Mixture glucose concentrations were 5.48 ± 0.65 mmol/L, 5.46 ± 0.6 mmol/L and 5.46 ± 0.64 mmol/L in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases for FC-Mixture glucose in all time points reached optimal analytical goals. In the second study, the biases for LH and FH glucose compared to reference FC-Mixture glucose exceeded the preset analytical goals, regardless of the blood collection to centrifugation time interval. CONCLUSIONS: FC-mixture tubes glucose concentrations were preserved up to 4h storage at RT. We confirmed that NaF alone does not allow immediate glycolysis inhibition in real life pre-centrifugation storage conditions (up to 340 minutes). FC-Mixture should be used exclusively for glucose determination in laboratories unable to implement the recommended blood samples’ treatment. |
format | Online Article Text |
id | pubmed-4783092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Croatian Society of Medical Biochemistry and Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-47830922016-03-15 Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis Bonetti, Graziella Carta, Mariarosa Montagnana, Martina Lo Cascio, Claudia Bonfigli, Anna Rita Mosca, Andrea Testa, Roberto Biochem Med (Zagreb) Research Article INTRODUCTION: Glycolysis affects glucose determination in vitro. The placement of sample tubes in ice-water slurry with plasma separation within 30 minutes is recommended, or alternatively the use of a glycolysis inhibitor. The aim of our two-steps study was to evaluate which Terumo tube is best for glucose determination in routine clinical setting. MATERIALS AND METHODS: In the first study, blood from 100 volunteers was collected into lithium heparin (LH), NaF/Na heparin (FH) and NaF/citrate buffer/Na(2)EDTA (FC-Mixture) tubes. LH sample was treated as recommended and considered as reference, while FH and FC-Mixture samples were aliquoted, maintained at room temperature (RT) for 1, 2 and 4 hours; centrifuged and plasma analysed in triplicate. In the second study, samples from 375 volunteers were collected in LH, FH and FC-Mixture tubes and held at RT before centrifugation from 10 to 340 minutes, depending on each laboratory practice. Samples were analysed in one analytical run. RESULTS: In the first study, FH glucose concentrations were 5.15 ± 0.66 mmol/L, 5.05 ± 0.65 mmol/L and 5.00 ± 0.65 mmol/L (P < 0.001) in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases in all time points exceeded the analytical goal for desirable bias based on biological variation criteria. FC-Mixture glucose concentrations were 5.48 ± 0.65 mmol/L, 5.46 ± 0.6 mmol/L and 5.46 ± 0.64 mmol/L in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases for FC-Mixture glucose in all time points reached optimal analytical goals. In the second study, the biases for LH and FH glucose compared to reference FC-Mixture glucose exceeded the preset analytical goals, regardless of the blood collection to centrifugation time interval. CONCLUSIONS: FC-mixture tubes glucose concentrations were preserved up to 4h storage at RT. We confirmed that NaF alone does not allow immediate glycolysis inhibition in real life pre-centrifugation storage conditions (up to 340 minutes). FC-Mixture should be used exclusively for glucose determination in laboratories unable to implement the recommended blood samples’ treatment. Croatian Society of Medical Biochemistry and Laboratory Medicine 2016-02-15 2016-02-15 /pmc/articles/PMC4783092/ /pubmed/26981020 http://dx.doi.org/10.11613/BM.2016.006 Text en |
spellingShingle | Research Article Bonetti, Graziella Carta, Mariarosa Montagnana, Martina Lo Cascio, Claudia Bonfigli, Anna Rita Mosca, Andrea Testa, Roberto Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis |
title | Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis |
title_full | Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis |
title_fullStr | Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis |
title_full_unstemmed | Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis |
title_short | Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis |
title_sort | effectiveness of citrate buffer-fluoride mixture in terumo tubes as an inhibitor of in vitro glycolysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783092/ https://www.ncbi.nlm.nih.gov/pubmed/26981020 http://dx.doi.org/10.11613/BM.2016.006 |
work_keys_str_mv | AT bonettigraziella effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT cartamariarosa effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT montagnanamartina effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT locascioclaudia effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT bonfigliannarita effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT moscaandrea effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT testaroberto effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis AT effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis |